Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers
Yuan Lin(Sun Yat-sen University), Guangmei Yan(Sun Yat-sen University), Jiankai Liang(Sun Yat-sen University), Xiaoke Zheng(The First Affiliated Hospital, Sun Yat-sen University), Yaqian Tan(Sun Yat-sen University), Xinwen Su, Jun Hu(Yichang Central People's Hospital), Haiyan Hu(Sun Yat-sen University), Liwu Fu(Sun Yat-sen University), Lipeng Tang(Guangzhou University of Chinese Medicine), Min Yan(Dalian Institute of Chemical Physics), Huijuan Shi(Sun Yat-sen University), Fang Wang(Sun Yat-sen University), Lijun Chen(Zhejiang International Studies University), Kai Li(China University of Geosciences (Beijing)), Haipeng Zhang(Jinan University), Wei Yin, Wenbo Zhu(Sun Yat-sen University), Yijun Huang(Fudan University), Xiao Xiao(Sun Yat-sen University), Xiaoxiao Yang, Pengxin Qiu, Sihan Wu(Children's Medical Center)
Cited by 167
Related Papers
KRAS mutation: from undruggable to druggable in cancer
|Signal Transduction and Targeted Therapy|2021|1k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
|Cancer Research|2010|348
ecDNA hubs drive cooperative intermolecular oncogene expression
|Nature|2021|334